Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 27,956,363
- Share change
- -592,693
- Total reported value
- $998,030,405
- Price per share
- $36.15
- Number of holders
- 59
- Value change
- -$18,654,367
- Number of buys
- 42
- Number of sells
- 26
Quarterly Holders Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 413197104:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
16%
|
9,064,036
|
$279,975,000 | — | 30 Sep 2020 | |
| Vivo Capital, LLC |
13F
|
Company |
7.9%
|
4,534,341
|
$153,714,000 | — | 30 Sep 2020 | |
| Novo Holdings A/S |
13F
|
Company |
6.5%
|
3,754,973
|
$127,294,000 | — | 30 Sep 2020 | |
| venBio Partners LLC |
13F
|
Company |
6.1%
|
3,504,624
|
$118,807,000 | — | 30 Sep 2020 | |
| Newlight Partners LP |
13F
|
Company |
4.6%
|
2,668,897
|
$90,476,000 | — | 30 Sep 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
874,909
|
$29,661,000 | — | 30 Sep 2020 | |
| Aisling Capital Management LP |
13F
|
Company |
1.5%
|
842,815
|
$28,571,000 | — | 30 Sep 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.76%
|
435,377
|
$14,759,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.72%
|
414,287
|
$14,044,000 | — | 30 Sep 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.69%
|
400,000
|
$13,560,000 | — | 30 Sep 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.57%
|
329,668
|
$11,176,000 | — | 30 Sep 2020 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
283,088
|
$9,597,000 | — | 30 Sep 2020 | |
| Logos Global Management LP |
13F
|
Company |
0.48%
|
275,000
|
$9,323,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.38%
|
219,593
|
$7,445,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.36%
|
209,361
|
$7,097,000 | — | 30 Sep 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.18%
|
101,212
|
$3,431,000 | — | 30 Sep 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.17%
|
97,203
|
$3,295,000 | — | 30 Sep 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.16%
|
94,580
|
$3,206,000 | — | 30 Sep 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.15%
|
83,598
|
$2,833,000 | — | 30 Sep 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.11%
|
61,030
|
$2,069,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
46,496
|
$1,576,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
38,063
|
$1,290,000 | — | 30 Sep 2020 | |
| MYDA Advisors LLC |
13F
|
Company |
0.06%
|
32,782
|
$1,111,000 | — | 30 Sep 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.04%
|
23,544
|
$798,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
22,000
|
$746,000 | — | 30 Sep 2020 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.03%
|
19,255
|
$653,000 | — | 30 Sep 2020 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.03%
|
14,500
|
$492,000 | — | 30 Sep 2020 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.02%
|
14,232
|
$482,000 | — | 30 Sep 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
12,500
|
$424,000 | — | 30 Sep 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.02%
|
12,275
|
$414,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
12,178
|
$413,000 | — | 30 Sep 2020 | |
| Avidian Wealth Enterprises, LLC |
13F
|
Company |
0.02%
|
12,000
|
$407,000 | — | 30 Sep 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
10,461
|
$355,000 | — | 30 Sep 2020 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
6,607
|
$224,000 | — | 30 Sep 2020 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.01%
|
6,236
|
$211,000 | — | 30 Sep 2020 | |
| Maven Securities LTD |
13F
|
Company |
0.01%
|
6,277
|
$206,000 | — | 30 Sep 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.01%
|
6,000
|
$203,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,240
|
$110,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$34,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
386
|
$12,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
250
|
$8,000 | — | 30 Sep 2020 | |
| Capital Analysts, LLC |
13F
|
Company |
0%
|
100
|
$3,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
50
|
$2,000 | — | 30 Sep 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
32
|
$1,000 | — | 30 Sep 2020 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q4 2020
As of 31 Dec 2020,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,956,363 shares.
The largest 10 holders included
FMR LLC, Vivo Capital, LLC, Novo Holdings A/S, venBio Partners LLC, Newlight Partners LP, JANUS HENDERSON GROUP PLC, Aisling Capital Management LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, PERCEPTIVE ADVISORS LLC, and BlackRock Inc..
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
44
Q4 2020 holders
59
Holder diff
15
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.